deltatrials
Unknown OBSERVATIONAL NCT01402232

REduction of rIsk for Contrast Induced Nephropathy (REICIN-RESCIND)

REduction of rIsk for Contrast-Induced Nephropathy (REICIN) Study:RESCIND-P (Prospective Observational Study for REduction of contraSt-induced Nephropathy and Cardiaovascular Events followINg carDiac Catheterization)

Sponsor: Dongguan Kanghua Hospital

Conditions Contrast Induced Nephropathy
Updated 12 times since 2017 Last updated: Aug 1, 2018 Started: Jan 31, 2013 Primary completion: Feb 29, 2016 Completion: Nov 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01402232, this observational or N/A phase trial focuses on Contrast Induced Nephropathy and remains ongoing. Sponsored by Dongguan Kanghua Hospital, it has been updated 12 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotRecruiting~Sep 2017 – ~Apr 2018 · 7 months · monthly snapshotUnknown Status~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotUnknown Status~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotUnknown Status~Sep 2018 – ~Dec 2019 · 15 months · monthly snapshotActive Not Recruiting~Dec 2019 – ~Sep 2020 · 9 months · monthly snapshotActive Not Recruiting~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2023 · 30 months · monthly snapshotUnknown Status~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 12 months · monthly snapshotUnknown

Change History

12 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown Status → Unknown

  4. Jul 2023 — Jul 2024 [monthly]

    Unknown Status

  5. Jan 2021 — Jul 2023 [monthly]

    Unknown Status

▶ Show 7 earlier versions

  1. Sep 2020 — Jan 2021 [monthly]

    Unknown Status

    Status: Active Not Recruiting → Unknown Status

  2. Dec 2019 — Sep 2020 [monthly]

    Active Not Recruiting

  3. Sep 2018 — Dec 2019 [monthly]

    Active Not Recruiting

    Status: Unknown Status → Active Not Recruiting

  4. Jun 2018 — Sep 2018 [monthly]

    Unknown Status

  5. Apr 2018 — Jun 2018 [monthly]

    Unknown Status

    Phase: NA → None

  6. Sep 2017 — Apr 2018 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  7. Jan 2017 — Sep 2017 [monthly]

    Recruiting NA

    First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dongguan Kanghua Hospital
  • Dongguan People's Hospital
  • First Affiliated Hospital, Sun Yat-Sen University
  • First People's Hospital of Kashgar
  • Futian People's Hospital
  • Guangdong Medical College
  • Guangdong Provincial People's Hospital
  • Guangzhou General Hospital of Guangzhou Military Command
  • Longyan City First Hospital
  • Maoming People's Hospital
  • Nanfang Hospital, Southern Medical University
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Data source: Guangdong Provincial People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations